About Inspect-IR

InspectIR has developed a disruptive mobile technology capable of identifying volatile organic compounds (VOCs) in as little as 90 seconds.
Device is current under FDA Emergency Use application for immediate utility for COVID-19 testing.

• Utilizes patented technology to capture volatile organic compounds (VOCs) from the breath for analysis and reporting.

• Capable of differentiating between 300+ VOCs - including ketones and aldehydes identifying COVID-19, Influenza A, SARS and more.

• Fully mobile testing unit, small enough to fit in a carry-on bag.

• Non-invasive, rapid COVID-19 testing with exceptional accuracy.

Tagged with

HardwareBiotechnologyMedical DevicesHealthcare

Problem statement

Disease detection is costly and uncomfortable for patients. The pandemic has only accelerated the demand for low cost and easy to use disease detection technology.

Traction information

- Clinical Trial was performed and results were submitted to FDA with EUA Application
- 1 patent issued
- Raised 2.7M
- Negotiating with large corporate partners, 1M+ deal with Dallas Mavericks

Updates

Audrey Haugh has visited this profile using a private link.

Added 6 months ago

Chrissy Liotta has visited this profile using a private link.

Added almost 2 years ago

Michael Morton has visited this profile using a private link.

Added over 2 years ago

Emilio Caamano has visited this profile using a private link.

Added over 2 years ago

Feng Chi Wang has visited this profile using a private link.

Added over 2 years ago

Feng Chi Wang has visited this profile using a private link.

Added over 2 years ago

McKaye Black has visited this profile using a private link.

Added over 2 years ago

Profile created.

Added over 2 years ago

Funding

Not raising capital right now

Total raised to date:$2,700,000